Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) are highly reactive oxygen-containing molecules, such as superoxide radicals and hydrogen peroxide, that are generated as natural byproducts of cellular metabolism (NCBI, PMC3070774). ROS-generating systems include enzymes like NADPH oxidases (NOX), xanthine oxidase, and the mitochondrial electron transport chain, which play vital roles in cell signaling and the immune response (PubMed, 22703241). However, an imbalance between ROS production and antioxidant defenses leads to oxidative stress, which causes damage to DNA, proteins, and lipids (NIH, 2023). This damage is a key driver in the pathogenesis of various conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders like Alzheimer's (PubMed, 28249118). Therapeutic interventions target these systems through direct scavenging of radicals, inhibition of ROS-producing enzymes, or the induction of endogenous antioxidant pathways (PubChem). Despite their potential, therapeutic targeting is complicated by the need to preserve physiological ROS levels required for normal cellular communication and host defense (PubMed, 23953108).
Mechanisms include direct neutralization of reactive species (scavenging), inhibition of enzymatic sources such as NADPH oxidase or xanthine oxidase, and pharmacological activation of the Nrf2-mediated antioxidant response.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and ROS-generating systems (ROS).